Author

Johanna S. Ungerstedt

Linköping UniversityORCID 0000-0002-0202-7296Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:long-read sequencing· 1 Research Focus:protein structure prediction· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Alexandra Argyriou· 1 shared Ann-Charlotte BjörklundiD· 1 shared Axel RoselliD· 1 shared Caroline KubaczkaiD· 1 shared Christina Maria Perraki· 1 shared Dennis A. Bosch· 1 shared Eva Hellström-Lindberg· 1 shared Fredrik Fagerström‐Billai· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra Argyriou

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

RNA splicing factor mutations drive myeloid neoplasm oncogenesis through protein complex poisoning

Pedro Luís Moura, Rui Mamede Branca, Yaroslav Kaminskiy, Ioannis Siavelis, Kovi R Shrung, Sophia Hofmann, Christina Maria Perraki, Alexandra Argyriou, Sadaf Fazeli, Masahiro M Nakagawa, Teresa Mortera Blanco, Steffen Boettcher, Caroline Kubaczka, Thorsten M. Schlaeger, Maria Creignou, , Eva Hellström-Lindberg

This study identifies how RNA splicing factor mutations drive myeloid neoplasm by disrupting proteomic networks through mis-splicing, validated via single-cell transcriptomics and proteomics.

bioRxiv · Sep 30, 2026 · PreprintCancer Biology

Plasma proteome screen of individuals with elevated blood counts to identify diagnostic signatures and biomarkers inherent to patients with myeloproliferative neoplasms

Xiangfu Zhong, Ingrid E. J. Lundahl, Axel Rosell, Roza Chaireti, Johanna S. Ungerstedt

The paper identifies plasma proteome biomarkers distinguishing myeloproliferative neoplasms from non-MPN individuals with elevated blood counts, finding TFRC as a specific marker for polycythemia vera.

bioRxiv · Aug 4, 2026 · PreprintCancer Biology